Relmada Therapeutics (RLMD) files mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: RLMD) | Delayed: 3.17 +0.07 (2.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.10 | 52 Week High | $4.10 | |||
| Open | $3.11 | 52 Week Low | $0.87 | |||
| Day High | $3.21 | P/E | N/A | |||
| Day Low | $3.08 | EPS | $0.00 | |||
| Volume | 453,575 | |||||
